← All trials
NCT04940520
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Nov 30, 2020
- Completion date
- May 1, 2021
- First posted
- Jun 25, 2021
- Last posted
- Jun 30, 2021
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidade do Vale do SapucaiLead sponsor
- Universidade do Vale do SapucaiReponsible party - principal investigator
- Universidade do Vale do SapucaiOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.